Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS-Reference-Cited by-同舟云学术

Discontinuation of Denosumab therapy for osteoporosis: A systematic review and position statement by ECTS

Published:2017-12 Issue: Volume:105 Page:11-17
ISSN:8756-3282
Container-title:Bone
language:en
Short-container-title:Bone

Author:

Tsourdi Elena,Langdahl Bente,Cohen-Solal Martine,Aubry-Rozier Bérengere,Eriksen Erik Fink,Guañabens Nuria,Obermayer-Pietsch Barbara,Ralston Stuart H.,Eastell Richard,Zillikens M. Carola

Publisher

Elsevier BV

Subject

Histology,Physiology,Endocrinology, Diabetes and Metabolism

Reference44 articles.

1. Bisphosphonates: the first 40years;Russell;Bone,2011

2. Bisphosphonate binding affinity as assessed by inhibition of carbonated apatite dissolution in vitro;Henneman;J Biomed Mater Res A,2008

3. Effects of continuing or stopping alendronate after 5years of treatment: the Fracture Intervention Trial Long-Term Extension (FLEX): a randomized trial;Black;JAMA,2006

4. The effects of 3 versus 6years of zoledronic acid treatment of osteoporosis: a randomised extension to the HORIZON-pivotal fracture trial (PFT);Black;J Bone Miner Res,2012

5. Managing osteoporosis in patients on long-term bisphosphonate treatment: report of a task force of the American Society for Bone and Mineral Research;Adler;J Bone Miner Res,2016

Cited by 387 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

2. Bone Metabolism, Bone Mass, and Bone Structure During Pregnancy and Lactation;Endocrinology and Metabolism Clinics of North America;2024-09

3. Research trends and hotspots on osteoporosis: a decade-long bibliometric and visualization analysis from 2014 to 2023;Frontiers in Medicine;2024-08-29

4. Update on Atypical Femoral Fractures;Journal of Bone and Joint Surgery;2024-08-22

5. Os tumoral;Revue du Rhumatisme;2024-08